Uneasy Calm At Fidelity Bank: When Silence, Succession And Scrutiny Collide

On the trading floor, nothing looks wrong with Fidelity Bank. The ticker still flashes green and red, the price still moves, brokers still call it a buy, and on the high street the branches are busy, the queues are long, the app still works. But ask a fund manager what Fidelity earned in the last six months and you will get a shrug, not a number. Ask when the next chief executive will be named and you will get a process, not a name. Ask if there will be a dividend and you will get silence.
That is the strange position Fidelity finds itself in as 2026 draws to a close: a bank that is visibly alive and yet financially invisible. It is not in crisis, it has not been suspended, it has not issued a profit warning. It has simply stopped telling the market what it is worth, and in a market built on disclosure, that silence has become the loudest signal of all.
Unlike the giants that can afford to make investors wait, Fidelity cannot. It spent the last three years fighting to be taken seriously as a tier-one bank, raising capital, crossing the N500 billion threshold, posting record revenue, and convincing retail investors who bought into its public offer that it had left its mid-tier past behind. Now, with its half-year and third-quarter results trapped between an unfinished audit and an unhurried regulator, and with its long-serving managing director preparing to step aside, that hard-won credibility is being tested not by a bad result, but by no result at all.
The timeline shows how a routine filing turned into a credibility test. On 21 August 2026, Fidelity Bank informed shareholders, the Nigerian Exchange and other stakeholders of a potential delay in publication of its audited financial statements for the half year ended 30 June 2026. Unlike UBA, whose Board had already approved its H1 accounts on 13 August 2026, Fidelity said the audit was still being finalised and upon completion, the statements would be presented to the Central Bank of Nigeria for approval and thereafter published. It obtained an NGX extension to 30 September 2026, subject to receipt of regulatory approval from the CBN. That extended deadline also lapsed without publication. In a notice dated 5 October 2026, it disclosed that it had obtained a further extension, with publication now tied to regulatory approval, but with no fresh specific date. The trading window, which in August was to stay closed until 24 hours after publication of the H1 audited accounts, was then expanded to stay closed until 24 hours after publication of both the H1 audited accounts and the unaudited Q3 accounts for the nine months ended 30 September 2026. At its 38th Annual General Meeting, held virtually on 9 October 2026, shareholders commended the bank’s 2025 performance but raised concerns about the delay, and the Chairman acknowledged the ongoing process, without giving a timeline. Delay, in other words, is not just a CBN queue for Fidelity. It is audit plus CBN, and that double delay is what makes the calm so uneasy.
That double delay points to the likely reasons behind the hold-up, and they are both technical and strategic. The first likely reason is the CBN’s system-wide tightening of scrutiny. The publication of audited H1 2026 statements for Access, UBA and Fidelity remains in limbo as the CBN steps up oversight of banks’ asset quality, credit provisioning and foreign currency risk exposures. The CBN’s heightened review reflects a systemic effort to stress-test bank balance sheets against elevated loan impairments, ongoing capital adequacy requirements, and sovereign restructuring risks before clearing interim audited accounts. This is the first set of audited accounts filed since the industry’s recapitalisation, and it comes ahead of possible interim dividends. For Fidelity, that scrutiny lands on a balance sheet that has just been rebuilt to meet recapitalisation. In December 2025 it completed a private placement that lifted eligible capital to N532.6 billion against the N500 billion regulatory minimum, and later to N564.5 billion, with capital adequacy ratio rising to 30.94 per cent in one presentation and falling to 16.21 per cent in another audited presentation, a swing that itself shows how sensitive the bank’s capital position is to how derivatives, risk-weighted assets and private placement proceeds are recognised. A regulator will not clear that quickly.
The second likely reason is derivatives and earnings sustainability, and here Fidelity’s own 2025 numbers explain why the CBN would want to look twice. Fidelity posted N1.52 trillion in gross earnings for 2025, a 45.6 per cent jump that marks the highest revenue in the bank’s history, but profit after tax fell 12.8 per cent to N242.44 billion from N278.1 billion in 2024. Profit before tax fell 9.7 per cent to N347.66 billion from N385.2 billion. The single biggest drag was a N223.8 billion derivative loss, a reversal from a N57.9 billion derivative gain a year earlier, which turned non-interest revenue negative and masked a strong core: net interest income of N831.35 billion, up 32 per cent, an industry-leading NPL ratio of 2.38 per cent, and a 61.71 per cent decline in impairment charges to N21.61 billion. In Q1 2026, the pattern continued: gross earnings climbed 37.9 per cent to N434.95 billion, profit before tax reached N92.48 billion, but profit after tax fell 18.2 per cent to N74.47 billion from N91.10 billion as rising funding costs and loan impairments squeezed margins. In Q3 2025, the same volatility was visible: gross earnings rose 8.04 per cent to N366.11 billion, interest income rose 40.44 per cent to N319.76 billion, but interest expense grew 108.18 per cent to N174.93 billion, foreign currency revaluation gains fell 84.26 per cent to N14.09 billion, and pre-tax profit fell 50.77 per cent to N87.67 billion. A bank whose profit can be halved in a quarter by derivatives and funding costs is exactly the bank a regulator will ask to prove that its H1 profit is distributable, not just accounting.
The third likely reason is forbearance, dividends and capital preservation. In June 2025, the CBN directed banks with unresolved loan-forbearance exposures to suspend dividends, defer executive bonuses and halt new offshore investments until they had made adequate provisions. Fidelity, which had cut its loan book by 2.4 per cent to N4.28 trillion in 2025 and maintained a liquidity ratio of 66.5 per cent, well above the 30 per cent floor, chose to pay no dividend for 2025 at all, despite being profitable, to preserve capital to cross the N500 billion line. The board made no dividend proposal for the year, leaving shareholders who had participated in the 2024 public offer with no payout. If H1 2026 shows another derivative hit, or a rise in impairments, the CBN will not want to clear the accounts and, by implication, clear the way for an interim dividend, until it is satisfied that capital is real and not just the result of a private placement that was still being verified. Indeed, reports noted that Fidelity raised N227.05 billion as a private placement hit 87.7 per cent subscription after CBN verification, a reminder that even its capital raise needed regulatory sign-off.
The fourth likely reason, unique to Fidelity, is succession. At the same AGM where shareholders asked about delayed results, Chairman Mrs Amaka Onwughalu confirmed that the process to appoint a successor to Managing Director Dr Nneka Onyeali-Ikpe is under way, subject to CBN approval, without giving a completion date. The two pending disclosures, a new MD designate and the delayed H1 results, are now linked in investors’ minds: a bank in leadership transition is a bank where the regulator will be extra careful about what numbers are signed off, by whom, and with what forward guidance. A new CEO inheriting a set of accounts that later need restatement would be a governance failure for both the bank and the CBN, so the CBN has an incentive to delay until both the numbers and the successor are clean.
The implications of this delay are already visible, and for Fidelity they are sharper than for a giant like UBA because Fidelity is still proving it belongs in the top tier. First, price discovery has frozen. Investors are trading Fidelity on Q1 figures that are now more than six months old, while GTCO, Zenith, Stanbic IBTC and First HoldCo have already reported H1 results. Analysts are divided, with most recommending buy, one recommending sell, and others on hold, reflecting uncertainty about normalisation of derivative resolution, dividend payments and cost-efficiency trends. With a trailing P/E of 3.84x and P/B of 1.30x, the market cannot tell whether Fidelity is cheap because it is misunderstood, or cheap because something is wrong. Second, suspicion fills the vacuum even if there is no fault. Every week of silence allows the market to price in the worst case, higher impairments, another derivative loss, tighter capital, no dividend, and the fact that Fidelity’s delay began as an audit delay, not just a CBN delay, makes that suspicion harder to dismiss than for UBA, where the audit was said to be complete. Third, dividends are hostage. Fidelity paid no final dividend for 2025, and there is no guarantee of an interim dividend for H1 2026 if the CBN forces higher provisioning or insists on capital retention. Fourth, governance is strained. The closed period will continue until 24 hours after both H1 and Q3 are released, which means insiders cannot trade, analysts cannot update models, and the bank cannot credibly guide the market on its outlook, because any guidance would be based on numbers the market cannot see, and at the same time it cannot announce its next CEO.
There is also a systemic implication that goes beyond Fidelity. When the regulator is silent and the bank is silent, the market learns to distrust both. The CBN has given no public explanation of the approval queue, its scope, or its expected resolution, and Fidelity has given no new publication date. That double silence creates an information asymmetry that favours those with private access over the retail shareholder who bought Fidelity in its public offer on the promise of transparency and dividends. It also weakens the NGX itself, because extensions that were meant to be exceptional become normal, and a deadline of 30 September that is missed without sanction teaches every other issuer that disclosure timelines are negotiable if you can cite audit finalisation and regulatory approval.
None of this proves that Fidelity is in trouble. It may be that the CBN will clear the accounts tomorrow, that H1 profit is resilient, that the derivative book has been cleaned, that the NPL ratio remains at 2.38 per cent, that capital remains above N500 billion, that a dividend will follow, and that the delay will be remembered as prudence, not concealment. The critical judgment, for now, is that Fidelity’s delay should be read as regulatory and audit-related, but not innocent. The fact that the bank said its audit was still being finalised in August, and then said it was awaiting CBN approval in October, suggests the hold-up moved from the auditor’s desk to the regulator’s desk, but never left the building. And when a bank that just posted its highest revenue ever, yet paid no dividend because of derivative losses, then enters a CEO succession, then cannot publish its next set of audited numbers for more than 114 days, the uneasy calm is not just about a late filing. It is about a market being asked to trust a bank in transition and a regulator in tightening mode at the same time, without being shown the numbers that would justify that trust, and the longer that calm lasts, the more it feels like the silence before a repricing, not the silence before a return to normal.



